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Abstract 
 
Background: Carcinogenesis of adenocarcinoma of the prostate occurs due to dysregulation of zinc level within the 
cells. Intracellular zinc molecules influx is regulated by a transporter protein ZIP1, whose non-presence is predicted to 
inhibit apoptosis, thus leads to the development of prostate adenocarcinoma. Methods: This study was aimed to analyse 
the correlation of ZIP1 and Caspase-3 expression in prostate adenocarcinoma on its grading as represented by Gleason 
Score. This was a cross-sectional, retrospective analytical study on 31 Formalin-fixed, paraffin-embedded tissue that 
meets inclusion criteria. The specimen was stained using the immune-histochemistry technique for ZIP1 and Caspase-3. 
Protein expression of each case was counted using ImageJ analysis. Gleason score was acquired as secondary data from 
the cases' reports. The correlation of their expression with respect to Gleason score was analysed with Pearson’s 
correlation using SPSS 11.5. Results: Mean expression level of ZIP1 and Caspase-3 in prostate adenocarcinoma were 
35% and 33%, respectively. There was a significantly positive correlation between ZIP1 and Caspase-3 expression 
(r = 0.379; p = 0.018). However, their correlation was stronger in intermediate-grade group (r = 0.73; p = 0.01) and the 
correlation was much weaker in high-grade group (r = 0.04; p = 0.48). Conclusions: There was a positive correlation 
between ZIP1 and Caspase-3 expression in prostate adenocarcinoma. 
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Introduction 
 
Prostate cancer is one of the most common 
malignancies occurring in mention the worldwide, with 
increasing incidence especially in developing countries 
and is often diagnosed at an advanced stage.1 The 
incidence of prostate cancer in Indonesia ranks the third 
after lung and colon cancer.2 Because of highly 
incidence of prostate cancer in Indonesia, searching the 
best therapeutic method for early detection, diagnosis, 
and treatment of prostate cancer needs to be done. 
The development of prostate cancer occurs due to changes 
in the characteristic of cell proliferation and apoptosis. 
The normal prostate gland produces fluid, prostatic 
secretions that contain a variety of essential cell 
proliferation and apoptosis elements such as zinc, citric, 
and prostate-specific antigen (PSA) biomarkers.3 The 
Accumulation of intracellular zinc influenced zinc 
transporters in the plasma membrane and intracellular 
membranes. ZIP1 proteins that contained in the 
basolateral membrane of the epithelial prostate is a 
major transporter of zinc into the cell carrier. Some 
research report ZIP1 transport activity and high 
accumulation of zinc have influence tumour suppressor 
activity guard cells undergone plastic malignancies.4 
Based on the various references, it was mentioned that 
there is a relationship between protein expression ZIP1 
as the gateway of zinc ions into cells that spur apoptosis 
and Caspase-3 activation as executor of apoptosis protein 
in prostate adenocarcinoma histological grade Gleason 
score system. This study aims to determine the role of 
transporter proteins in the process of development of 
malignancy ZIP1 prostate cancer. Also, this study also 
seeks to analyse the level of protein expression and 
activation ZIP1 caspase-3 as well as the correlation both 
in prostate adenocarcinoma tissues with different Gleason 
score. 
 
Methods 
 
The study design was a cross-sectional retrospective 
analytical study design. The research subject is a paraffin 
block prostate adenocarcinoma which had been diagnosed 
by a medical anatomical pathology doctor specialist 
with complete data Gleason score (GS). All data contain in 
the archive department of pathology-anatomy, Faculty of 
Medicine, Universitas Indonesia and Cipto Mangunkusumo 
Hospital (RSCM). The specimen was stained using the 
immune-histochemistry technique for ZIP1 and Caspase-3. 
Based on the Gleason score, subjects were divided into 
five groups: GS6, 7GS, GS8, 9GS, and GS10. 
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Calculation of sample size. The sample size was 
calculated using the formula correlation with alpha = 5% 
and a confidence level = 95%. Large samples are obtained 
as many as 31 samples for each antibody treatment. 
 
Slide preparation and immuno-histochemistry. Paraffin 
blocks were taken from patients FKUI based HE 
preparations that verified by Anatomical Pathology 
specialists. Paraffin blocks were cut with a thickness of 
4µm and placed on microscope slides. Slides were dried 
in an oven at a temperature of 60 °C for 30 minutes. 
 
Immuno-histochemistry smear using Streptavidin-
Biotin complex labelling methods. Primary antibodies 
were used to label ZIP1 is primary antibody rabbit 
polyclonal anti-human ZIP1 (Abcam technologies) 
dilution 1 : 2000, while for Caspase-3 used primary 
antibody mouse monoclonal anti-human Caspase-3 
(Santa Cruz) dilution 1 : 1600. Included negative 
control for each case and a positive control for each 
batch of staining. 
Assessment ZIP1 expression and Caspase 3 conducted 
on 500 tumour cells from 5 different visual fields 
(magnification 400×) were selected randomly. Each 
represents the field of view of 100 tumour cells. Protein 
expression tested positive (+) if the chocolate stained 
on the cytoplasmic membrane and cytoplasm of tumour 
cells to antibody ZIP1 and chocolate stained on the 
cytoplasmic Caspase-3 antibodies. Stained cell count 
performed using ImageJ program (Figure 1 & Figure 2). 
 
Data analysis using SPSS software version 11.5 are 
descriptive statistics, testing normality using the Shapiro-
Wilk test. Comparison of expression profiles ZIP1 and 
Caspase-3 prostate cancer tissue in a variety of Gleason 
score is used Kruskal-Walis test or Analysis of Variants 
(ANOVA). The correlation between the expression of 
Caspase-3 ZIP1 and prostate cancer tissue at different 
Gleason scores with Pearson correlation testor Spearman 
alternative test. Furthermore, the data will be presented 
in the form of narratives, images, and tables. 
 
   
 
Figure 1. Expression of Negative and Positive Immune-Histochemical Staining in Prostate Adenocarcinoma (Magnification 
400x). (a) Negative Expression (b) The Expression of Caspase-3 Positive 
 
    
 
Figure 1.  Expression of Negative and Positive Immuno-Histochemical Staining in Prostate Adenocarcinoma (Magnification 
400x). (a) Negative Expression (b) Expression Positive ZIP1 
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Results  
 
This study used 31 cases were confirmed as prostate 
adenocarcinoma that comes from prostatectomy outcomes 
preparation and meets the inclusion criteria Immunohisto-
chemical examination of the 31 cases studied were 
grouped by system Gleason Score (GS) to obtain cases 
of adenocarcinoma with GS6 counted 4 cases, GS7 
counted 9 cases, GS8 counted 3 cases, GS9 counted 11 
cases, and GS10 counted 4 cases. 
 
Table 1 shows the expression of prostate adenocarcinoma 
ZIP1 on the level of Gleason score (GS) significant 
relationship (p = 0.08). While the expression of Caspase-3 
in prostate adenocarcinoma with different GS was found 
significantly different (p = 0.841). 
 
In the biomolecular mechanisms, ZIP1 protein acts as a 
zinc transporter. Allegedly the increase in protein 
expression ZIP1 will increase the expression of the 
Caspase-3 protein. To see the relationship between the 
protein and Caspase-3 ZIP1 done analysis Pearson 
correlation. Results correlation ZIP1 expression and 
Caspase-3 in prostate adenocarcinoma can be seen in 
Figure 3. 
 
This analysis found a significant positive correlation 
between protein expression ZIP1 and Caspase-3 (r = 0.379 
and p = 0.018). The higher expression significantly ZIP1 
followed by increased expression of Caspase-3. To see 
ZIP1 and Caspase-3 protein expression in prostate 
adenocarcinoma group of intermediate grade (GS 6-7) 
and high grade (GS 8-10) performed women different 
analyses; the results are shown in Figure 4. The results 
of the statistical calculation obtained analysis results of 
the mean ZIP1 protein expression in intermediate-grade, 
and high-grade prostate adenocarcinoma did not differ 
significantly (p = 0.76), as did the mean Caspase-3 protein 
expression in prostate adenocarcinoma in the intermediate 
grade and high grade did not differ significantly (p = 0.15). 
 
Table 1.  Expression of ZIP1 and Caspase-3 Protein per Group Gleason Score based on the Mean Number of Smear-positive (+) 
Cells in Prostate Adenocarcinoma 
 
Prostate adenocarcinoma 
(Grade GS) Number of Case (n) 
Marker Expression 
ZIP1 Caspase-3 
GS 6 4 32.25+2.52 30.50+2.30 
GS 7 9 28.11+1.87 36.89+2.16 
GS 8 3 17.00+6.24 23.33+2.15 
GS 9 11 49.27+2.36 33.91+1.58 
GS 10 4 31.75+7.13 37.00+1.22 
mean  35.55+2.18 33.71+1.80 
p  Kruskal-Walis test = 0.08 ANOVA test = 0.841 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 3. Graph Correlation ZIP1 Protein and Caspase-3 Protein in Prostate Adenocarcinoma 
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Figure 4. Comparison of ZIP1 and Caspase-3 Mean Protein Expression in the Preparation of Prostate Adenocarcinoma 
 
 
 
 
       
 
 
 
 
 
 
 
Figure 5.  Graph Correlation ZIP1 Protein and Caspase-3 Protein in Prostate Adenocarcinoma. (a) the Average ZIP1 
Correlation with Caspase-3 in the Intermediate Grade (b) the Average Correlation ZIP1 with Caspase-3 in High 
Grade (a) The Mean of ZIP1 Expression in Intermediate Grade and High Grade (b) The Mean of Caspase-3 in the 
Intermediate Grade and High Grade 
 
 
Further, analysis of the correlation between protein 
expression ZIP1 and Caspase-3 protein on Gleason 
Score intermediate grade and high grade shows the 
results as shown in Figure 5. 
 
There is a significant positive interaction (r = 0.73, 
p = 0.002) between ZIP1 protein expression with 
Caspase-3 protein expression in the group of 
intermediate grade (GS 6-7), increasing the ZIP1 protein 
expression significantly will be followed by increased 
the expression of Caspase-3 and in another side, the 
group of high-grade (GS 8-10) the relationship between 
the expression of ZIP1 protein with Caspase-3 protein 
expression is very weak and not significant (r = 0:04, 
p = 0:48). 
Discussion 
 
Studies of cytotoxic or tumour suppressor effects of zinc 
in support of a potential zinc treatment approach for 
prostate cancer is scattered among many published 
reports. Malignant prostate zinc levels are markedly 
decreased in all cases of prostate cancer compared to the 
normal/benign prostate. ZIP1 zinc transporter down 
regulation decreases zinc to prevent its cytotoxic effects. 
Thus, prostate cancer is a “ZIP1-deficient” malignancy.5 
ZIP1 protein known tobe expressed in several carcinomas 
such as prostate and breast carcinoma. In this study, the 
positivity ZIP1 on prostate cancer are lower than in 
normal prostate. This is in line with research Franklin et 
al. which implies positivity ZIP1 in prostate cancer by 
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32% and 75% of normal prostate.6 ZIP1 protein 
expression was lower in prostate cancer is thought to 
cause lower levels of zinc in prostate carcinoma. This is 
because ZIP1 is for the zinc transporter protein that 
would cause the loss of the ability of prostate epithelial 
cells to accumulate zinc and affect the activity of cell 
proliferation so inhibition of apoptotic cells that can 
contribute to prostate carcinogenesis. 
 
Decreased ZIP1 expression in prostate adenocarcinoma 
associated with epigenetic factors that regulate expression 
of the ZIP1 protein.6 This is evidenced by research 
Hlavna et al. who stated there was no significant 
difference in mRNA expression between normal 
prostate cells with prostate cancer.7 Decreased protein 
ZIP1 allegedly because of epigenetic factors, that is 
deregulation of the post-transcriptional stage that causes 
the ZIP1 mRNA not translated into functional proteins. 
 
The epigenetic factors are micro RNA (miRNA) that 
involved in the inhibition of ZIP1 protein synthesis. One 
of miRNAs that inhibit the ZIP1 expression is 
miRNA224. This gene is known to elevate in some 
human prostate cancer cell lines. Also, it also inhibits 
the expression of micro-RNA metallothionein (MT), the 
zinc-binding protein that acts as a buffer and donor zinc 
on intracellular processes.7 
 
In this research is also known a decrease in the 
expression of Caspase-3 in prostate adenocarcinoma 
were suspected because of the post-translational change 
break down pro Caspase-3 into Caspase-3. Modification 
of proteolytic breakdown of precursor form scan causes 
low levels of activated Caspase-3.8 Estrow et al. states 
that the low levels of Caspase-3 indicate a poor 
prognosis is because most of the Caspase-3, undivided 
and unactivated.9 It is thought to be a mechanism of 
inhibition of apoptosis that supports the development of 
cancer. 
 
Figure 1 shows a significant positive correlation between 
ZIP1 and Caspase-3 protein expression. This positive 
relationship can be explained by the possibility of 
changes in protein expression ZIP1 which has the lead 
roles an intracellular zinc transporter, causing changes 
in the levels of zinc in cells that trigger the apoptotic 
signalling cascade, including changes in the activation 
of Caspase-3. Decreased levels of zinc and citrate 
occurred starting from the beginning of malignancy.10 
Low Zinc levels can also inhibit apoptosis through the 
intrinsic cell death pathway. It is characterised by a 
decrease in mitochondrial membrane potential, followed 
by caspase activation.3 Caspase-3 are present in the 
active form can be inhibited by zinc because activation 
of catalytic caspase motif consisting of cysteine and 
histidine residues can be bound to zinc on one or both 
residues the amino acids.11 
 
Further, the analysis examines the correlation ZIP1 
expression and activity of Caspase-3 in different 
Gleason score (Figure 5), showed that there was the 
positive correlation in prostate adenocarcinoma group 
GS6, 7, and 8. In the GS9 and 10, the relationship is 
getting weaker. According to Franklin et al.12 grow than 
a development of prostate malignancies caused by the 
loss of the ability of prostate cells to accumulate zinc by 
decreased expression of the ZIP1 protein. Decreased zinc 
plays a role in the inhibition of the formation of 
membrane pores Bax combined with a decrease in the 
recruitment of cytosolic Bax, resulting in yeast 
cytochrome-c is released from mitochondria thus be 
reduce apoptotic signalling cascade including decrease in 
Caspase-3.10 
 
In this study, also did an analysis of the correlation 
between ZIP1 and Caspase-3 expression based Gleason 
score grading that is intermediate grade (GS 6 and 7) 
and a group of high grade (GS 8-10). The results of the 
analysis (Figure 5a) shows a significant positive 
correlation (r = 0.73) with linear R2 = 0.544 in the group 
of intermediate grade. This means that from the 
correlation, 54.4% activation of Caspase-3 is determined 
by the expression ZIP1, and other factors determine the 
balance. The reverse at the high-grade group, the 
correlation is very weak and not significant. Changes in 
the expression mechanism are made possible by the 
effect of a decrease in zinc levels that have occurred 
since the beginning of the development of cancer. Zinc 
act as s part of the DNA-binding proteins is known as 
zinc finger proteins that act as transcription factors that 
bind to short DNA sequences and control the 
transcription of various genes.13 Decreased levels of zinc 
resulted in the loss of the metal the zinc finger protein. 
 
The loss of zinc in the protein molecule can be replaced 
by other metals such as cobalt, cadmium, nickel, and 
iron. Replacement of zinc metal zinc finger protein 
binds to become one of the causes of carcinogenesis and 
DNA damage in cells. Cobalt and iron can cause the 
formation of H2O2, which catalyses the degradation of 
deoxyribose and induces DNA damage. So that decreased 
levels of zinc in prostate adenocarcinoma followed by 
molecular replacement zinc other metals are expected to 
form free radicals that cause damage to DNA (DNA 
mutation).13 The damage (mutations) in the DNA that 
occurs adenocarcinoma due to reduced levels of zinc 
(ZIP1 reduction effect) thought to have an impact on the 
level of malignancy of prostate adenocarcinoma. High-
grade GS group had a higher aggressiveness than the GS 
group of intermediate grade. Higher cell aggressiveness 
caused DNA mutations that occur in the cell indicated 
by the activation of Caspase-3 are no longer affected by 
the concentration of zinc in cells.  
 
Despite decades of research, no efficacious chemotherapy 
exists for the treatment of prostate cancer. A zinc 
Analysis Expression of ZIP1 and Caspase-3 Protein 
Makara J. Health Res.  April 2016 | Vol. 20 | No. 1 
23
ionophore (e.g. Clioquinol) treatment to increase malignant 
zinc levels is a plausible treatment for prostate cancer.5 
This research can be useful in supporting the determination 
of the dose of zinc ionophore treatment. 
 
Conclusions 
 
It was concluded that ZIP1 protein expression and 
Caspase-3 was not correlated with the Gleason Score, 
but it is also known is a positive relationship between 
the expression of Caspase-3 and ZIP1 with the 
adenocarcinoma of the prostate. 
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